|
EC 1.3.1.6 (fumarate reductase (NADH)) inhibitor
|
CHEBI_231760 |
|
|
paralytic squint
|
DOID_10863 |
|
|
convulsant
|
CHEBI_231761 |
|
|
inorganic acid
|
CHEBI_138103 |
|
|
Kuhnt-Junius degeneration
|
DOID_10873 |
|
|
age related macular degeneration
|
DOID_10871 |
|
|
antinociceptive agent
|
CHEBI_228138 |
|
|
C3a receptor antagonist
|
CHEBI_228139 |
|
|
Drosophila melanogaster
|
NCBITaxon_7227 |
|
|
Vd
|
BAO_0003040 |
|
|
Vdss
|
BAO_0003041 |
|
|
F
|
BAO_0003042 |
|
|
EC 3.5.3.1 (arginase) inhibitor
|
CHEBI_195561 |
|
|
EC 3.5.3.* (non-peptide linear amidine C-N hydrolase) inhibitor
|
CHEBI_195562 |
|
|
epidemic pleurodynia
|
DOID_10882 |
|
|
hand, foot and mouth disease
|
DOID_10881 |
|
|
kinase competitive binding method
|
BAO_0003032 |
|
|
mobility shift assessment method
|
BAO_0003033 |
|
|
MIC50
|
BAO_0003035 |
|
|
ED50
|
BAO_0003036 |
|
